Scarica l'app Stockscreener
23.88
1.57%
0.37
Dopo l'orario di chiusura:
23.75
-0.13
-0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Precedente Chiudi:
$23.51
Aprire:
$23.705
Volume 24 ore:
11.94M
Relative Volume:
1.24
Capitalizzazione di mercato:
$9.29B
Reddito:
$3.14B
Utile/perdita netta:
$-3.36B
Rapporto P/E:
-2.7354
EPS:
-8.73
Flusso di cassa netto:
$-4.03B
1 W Prestazione:
-3.83%
1M Prestazione:
-14.78%
6M Prestazione:
-31.02%
1 anno Prestazione:
-65.03%
Intervallo 1D:
$23.35
$23.95
Intervallo di 1 settimana:
$23.18
$25.90
Portata 52W:
$23.15
$75.37
Moderna Inc Stock (MRNA) Company Profile
Nome
Moderna Inc
Settore
Industria
Telefono
(617) 714-6500
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Confronta MRNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
23.88 | 9.15B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | Citigroup | Neutral |
| 2025-02-18 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-01-29 | Downgrade | Goldman | Buy → Neutral |
| 2024-12-18 | Downgrade | Argus | Buy → Hold |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-19 | Iniziato | Berenberg | Hold |
| 2024-11-18 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Underperform |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-09-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-09-13 | Downgrade | Jefferies | Buy → Hold |
| 2024-09-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-08-28 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2024-08-07 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-08-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | Downgrade | HSBC Securities | Hold → Reduce |
| 2024-01-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-11-29 | Iniziato | Canaccord Genuity | Hold |
| 2023-11-03 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-11-02 | Downgrade | Deutsche Bank | Hold → Sell |
| 2023-08-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-07-24 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Reduce |
| 2023-06-26 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-26 | Iniziato | Guggenheim | Neutral |
| 2023-03-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-24 | Downgrade | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-12-14 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | Aggiornamento | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-02-01 | Aggiornamento | Redburn | Sell → Neutral |
| 2022-01-26 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-21 | Iniziato | UBS | Neutral |
| 2021-12-07 | Iniziato | Cowen | Market Perform |
| 2021-11-09 | Iniziato | Wolfe Research | Outperform |
| 2021-10-22 | Iniziato | Deutsche Bank | Sell |
| 2021-10-15 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-08-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | Reiterato | Jefferies | Hold |
| 2021-02-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | Downgrade | Needham | Buy → Hold |
| 2020-11-23 | Iniziato | Wells Fargo | Equal Weight |
| 2020-11-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-07-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Iniziato | Jefferies | Buy |
| 2020-06-30 | Iniziato | Argus | Buy |
| 2020-06-08 | Iniziato | Barclays | Overweight |
| 2020-04-30 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | Ripresa | BofA/Merrill | Buy |
| 2019-10-25 | Iniziato | ROTH Capital | Buy |
| 2019-04-05 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Moderna Inc Borsa (MRNA) Ultime notizie
China’s Therapeutic mRNA Vaccine Pipeline For Oncology The Largest Globally - insights.citeline.com
MRNA Stock vs. PFE & ALNY - Forbes
Moderna (MRNA) Faces High Short Interest Despite Revenue Decline - GuruFocus
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths - Yahoo Finance
Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? - PharmaVoice
Voleon Capital Management LP Purchases Shares of 42,507 Moderna, Inc. $MRNA - MarketBeat
Woodline Partners LP Raises Position in Moderna, Inc. $MRNA - MarketBeat
Acadian Asset Management LLC Increases Stake in Moderna, Inc. $MRNA - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 11,270 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Moderna (NASDAQ:MRNA) Trading Down 5.6%Here's What Happened - MarketBeat
Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths - Fast Company
BRIEF—Moderna releases new statement on Spikevax - The Pharma Letter
Amundi Raises Position in Moderna, Inc. $MRNA - MarketBeat
Raymond James Financial Inc. Sells 100,752 Shares of Moderna, Inc. $MRNA - MarketBeat
Sessa Capital IM L.P. Makes New $21.07 Million Investment in Moderna, Inc. $MRNA - MarketBeat
Theleme Partners LLP Has $205.32 Million Position in Moderna, Inc. $MRNA - MarketBeat
Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths - Sherwood News
Moderna (MRNA) Affirms Safety of Spikevax Vaccine - GuruFocus
Moderna (MRNA) Declines More Than Market: Some Information for Investors - sharewise.com
Moderna Falls as Trump Officials Tie Child Deaths to Covid Shots - Bloomberg.com
Moderna reinforces that there are no new safety concerns for Spikevax vaccine - StreetInsider
Friday Sector Laggards: Healthcare, Materials - Nasdaq
S&P 500 Gains and Losses Today: Warner Bros. and Paramount Extend Gains; Moderna Plunges - Investopedia
Warner Bros., Paramount Skydance, Tesla, Moderna, IonQ, Gemini Space, Microsoft, and More Movers - Barron's
Drugmakers Fall on Report US to Claim Covid Shot Killed Kids - Yahoo Finance
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine - New York Post
Moderna’s Stock on Shaky Grounds: What Now? - StocksToTrade
Why Moderna (MRNA) Shares Are Trading Lower Today - TradingView
Moderna (MRNA) Shares Tumble Amid CDC Vaccine Concerns - GuruFocus
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths - Benzinga
Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths - Investing.com Canada
COVID vaccine names take a hit after report of child deaths CDC presentation - Seeking Alpha
Moderna (MRNA) Experiences Significant Drop in Stock Price - GuruFocus
Moderna stock drops on report that feds may link child deaths to vaccines - The Business Journals
Moderna, Pfizer stocks fall as Trump officials reportedly link COVID shots to child deaths - MarketWatch
Sept. consumer sentiment falls, Moderna & COVID report, Gemini IPO - Yahoo Finance
CDC to offer contract to study link between vaccines and autism - Seeking Alpha
HHS officials to pin 25 child deaths to COVID shots at upcoming meetingreport - Seeking Alpha
Jacobs Levy Equity Management Inc. Takes $28.31 Million Position in Moderna, Inc. $MRNA - MarketBeat
Vinay Prasad, back at FDA, becomes chief medical and scientific officer -- again - Seeking Alpha
USA Vaccine Market Outlook Report 2025-2030 | Pfizer, Moderna, J&J, Merck, and GSK Compete Through Innovation, Approvals, and Strategic PartnershipsResearchAndMarkets.com - Business Wire
Moderna Inc Azioni (MRNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.33%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):